Abstract
Objective
As life expectancy increases in patients with congenital heart disease (CHD), providing appropriate gynecological care has become more important. While the gynecologic and reproductive health concerns of adults with CHD are increasingly recognized, studies focusing on menstrual problems in adolescents with CHD are limited. The aim was to evaluate menstrual characteristics and related symptoms in adolescents with CHD.
Methods
Adolescents aged 12-21 years who had experienced menarche at least two years earlier were included. The CHD group was classified as mild, moderate, or severe, based on the European Society of Cardiology guidelines, and healthy adolescents served as controls. Menstrual histories were obtained from all participants. In the CHD group, additional clinical data (diagnosis, surgery/interventions, and medication use) were collected. Menstrual parameters were compared between the CHD and control groups, as well as across CHD subgroups.
Results
A total of 108 adolescents with CHD (41 mild, 42 moderate, 25 severe) and 76 healthy controls were enrolled. No significant differences were found between groups in terms of age at menarche, menstrual cycle length, period duration, or daily pad use (p>0.05). Dysmenorrhea severity and frequency were similar; however, school absenteeism due to dysmenorrhea was significantly higher in the control group (p=0.037). Physical premenstrual symptoms, particularly bloating, anxiety, and mood swings, were more frequent in controls (p<0.05). Menstrual education rates from healthcare professionals were low in both groups.
Conclusion
Our findings indicate that adolescents with CHD have menstrual characteristics comparable to those of healthy controls. However, despite these similarities, they may differ in their perception and tolerance of menstrual symptoms.
Keywords: Congenital heart disease, menstrual dysfunction, premenstrual symptom, premenstrual syndrome
Read the full text
5 sections · 4 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48:455-463.
Mandalenakis Z, Giang KW, Eriksson P, Liden H, Synnergren M, Wåhlander H, Fedchenko M, Rosengren A, Dellborg M. Survival in children with congenital heart disease: have we reached a peak at 97? J Am Heart Assoc. 2020;9:e017704. Epub 2020 Nov 6
Çetiner N, Çeliker A. Evaluation of the relationship between cardiopulmonary exercise test findings and clinical status in children and adolescents with congenital heart disease. Turk J Pediatr. 2022;64:1041-1049.
Akça Sümengen A, İsmailoğlu AV, İsmailoğlu P, Gümüş T, Çeliker A, Namlısesli D, Poyraz E, Özçevik Subaşı D, Zeren Erdem C, Çakır GN. The effect of 3D modeling on family quality of life, surgical success, and patient outcomes in congenital heart diseases: objectives and design of a randomized controlled trial. Turk J Pediatr. 2024;66:237-250. Epub 2024 May 23.
Canobbio MM, Rapkin AJ, Perloff JK, Lin A, Child JS. Menstrual patterns in women with congenital heart disease. Pediatr Cardiol. 1995;16:12-15.
Drenthen W, Hoendermis ES, Moons P, Heida KY, Roos-Hesselink JW, Mulder BJ, Van Dijk AP, Vliegen HW, Sollie KM, Berger RM, Lely AT, Canobbio MM, Pieper PG. Menstrual cycle and its disorders in women with congenital heart disease. Congenit Heart Dis. 2008;3:277-283.
Vigl M, Kaemmerer M, Niggemeyer E, Nagdyman N, Seifert-Klauss V, Trigas V, Bauer U, Schneider KT, Berger F, Hess J, Kaemmerer H. Sexuality and reproductive health in women with congenital heart disease. Am J Cardiol. 2010;105:538-541.
Khajali Z, Ziaei S, Maleki M. Menstrual disturbances in women with congenital heart diseases. Res Cardiovasc Med. 2016;5:e32512. Epub 2016 Jul 20.
Leroy-Melamed M, Katz A, Shew ML. Menstrual dysfunction and treatment among adolescents with congenital heart disease. J Pediatr Adolesc Gynecol. 2020;33:686-690.
Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, Mital S, Rose C, Silversides C, Stout K. American Heart Association Council on Cardiovascular and Stroke Nursing, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Cardiovascular Disease in the Young, American Heart Association Council on Functional Genomics and Translational Biology, American Heart Association Council on Quality of Care and Outcomes Research. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135:e50-e87.
Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:1494-1563. Epub 2018 Aug 16.
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F, Moons P, Mulder BJM, Oechslin E, Roos-Hesselink JW, Schwerzmann M, Sondergaard L, Zeppenfeld K, European Society of Cardiology. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42:563-645.
Sable C, Foster E, Uzark K, Bjornsen K, Canobbio MM, Connolly HM, Graham TP, Gurvitz MZ, Kovacs A, Meadows AK, Reid GJ, Reiss JG, Rosenbaum KN, Sagerman PJ, Saidi A, Schonberg R, Shah S, Tong E, Williams RG, Young AH. Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation. 2011;123:1454-1485.
Peña AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, Garad R, Dabadghao P, Teede H. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18:72. Epub 2020 Mar 24.
American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol. 2015;126:e143-e146.
Tiranini L, Nappi RE. Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Fac Rev. 2022;11:11. Epub 2022 Apr 28.
American College of Obstetricians and Gynecologists. Management of premenstrual disorders: ACOG clinical practice guideline no. 7. Obstet Gynecol. 2023;142:1516-1533.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Canobbio MM, Perloff JK, Rapkin AJ. Gynecological health of females with congenital heart disease. Int J Cardiol. 2005;98:379-387.
Haines C, Loades M, Davis C. Illness perceptions in adolescents with chronic fatigue syndrome and other physical health conditions: Application of the common sense model. Clin Child Psychol Psychiatry. 2019;24:546-563.
Akbulut Ö, Jafari L, Aygün Arı D, Pehlivantürk Kızılkan M, Derman O, Akgül S. Prevalence of premenstrual syndrome in adolescent girls. Turk J Pediatr. 2024;66:340-345.
